Impact of inhalational anesthetics on neurodegeneration in Alzheimer’s disease: current evidence and potential implications
Canadian Journal of Physiology and Pharmacology · 01.01.2026 · 104 · 1-9
DOI: 10.1139/cjpp-2025-0192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.01.2026. Verfasst von Austin Dosanjh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Pharmacology and Therapeutics, and Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vanc…. Hauptthemen laut MEDLINE: Alzheimer Disease, Anesthetics, Inhalation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Smith Health Research BC, Canadian Institutes of Health Research, Alzheimer Society Research Program.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common form of dementia, primarily affecting the elderly population. It is a progressive neurodegenerative disease with key pathogenesis hallmarks being amyloid-beta plaque accumulation, and neurofibrillary tangles of tau protein. With an increasingly aging population and rising numbers of surgical procedures, growing interest has been directed toward the potential impact of inhalational anesthetics, particularly isoflurane, sevoflurane, and desflurane, in contributing to the neurodegenerative process. Evidence supporting anesthetic-related modulation of AD pathways is derived predominantly from in vitro and animal models, with comparatively limited and heterogeneous human biomarker and clinical data. This review will explore the various mechanisms by which these volatile anesthetics may contribute to the pathogenesis of neurodegeneration in the context of AD. This includes upregulation of beta-secretase 1 resulting in the formation of amyloid-beta oligomers and inhibition of tau dephosphorylation. While certain studies point toward a neuroprotective effect of these anesthetics, the evidence remains inconsistent. Collectively, these findings support perioperative strategies focused on maintenance of normothermia, optimization of oxygenation, and judicious anesthetic exposure as practical measures to mitigate vulnerability in at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Pharmacology and Therapeutics, and Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
- Department of Medical Sciences, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi 127788, United Arab Emirates.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
ORCID-Profile: Khaled S Abd-Elrahman
Förderung
- Michael Smith Health Research BC
- Canadian Institutes of Health Research
- Alzheimer Society Research Program
Zitieren
APA
Dosanjh, A., Al-Jaf, S., Ye, E., & Abd-Elrahman, K. (2026). Impact of inhalational anesthetics on neurodegeneration in Alzheimer’s disease: current evidence and potential implications. Canadian Journal of Physiology and Pharmacology, 104, 1-9. https://doi.org/10.1139/cjpp-2025-0192
Vancouver
Dosanjh A, Al-Jaf S, Ye E, Abd-Elrahman K. Impact of inhalational anesthetics on neurodegeneration in Alzheimer’s disease: current evidence and potential implications. Canadian Journal of Physiology and Pharmacology. 2026;104:1-9. doi:10.1139/cjpp-2025-0192
BibTeX
@article{Dosanjh2026,
author = {Dosanjh, Austin and Al-Jaf, Sanarya and Ye, Emily and Abd-Elrahman, Khaled S},
title = {Impact of inhalational anesthetics on neurodegeneration in Alzheimer’s disease: current evidence and potential implications},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2026},
volume = {104},
pages = {1--9},
doi = {10.1139/cjpp-2025-0192}
}
EUVIMED